Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Kadmon Holdings Llc (KDMN)

Kadmon Holdings Llc (KDMN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,504,616
  • Shares Outstanding, K 172,350
  • Annual Sales, $ 8,290 K
  • Annual Income, $ -108,910 K
  • 60-Month Beta 1.63
  • Price/Sales 183.41
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade KDMN with:

Options Overview

Details
  • Implied Volatility 71.84%
  • Historical Volatility 187.68%
  • IV Percentile 3%
  • IV Rank 13.25%
  • IV High 283.72% on 10/08/20
  • IV Low 39.48% on 09/10/21
  • Put/Call Vol Ratio 0.77
  • Today's Volume 2,985
  • Volume Avg (30-Day) 7,815
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 51,965
  • Open Int (30-Day) 42,073

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.20
  • Number of Estimates 4
  • High Estimate -0.18
  • Low Estimate -0.21
  • Prior Year -0.15
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.63 +88.55%
on 08/18/21
9.20 -5.11%
on 09/08/21
+3.82 (+77.80%)
since 08/17/21
3-Month
3.53 +147.31%
on 07/15/21
9.20 -5.11%
on 09/08/21
+4.55 (+108.85%)
since 06/17/21
52-Week
3.14 +177.58%
on 11/02/20
9.20 -5.11%
on 09/08/21
+4.23 (+94.00%)
since 09/17/20

Most Recent Stories

More News
Lifshitz Law Firm, P.C. Announces Investigation of CXP, HRC, KDMN, and JMP

NEW YORK, NY / ACCESSWIRE / September 18, 2021 / Lifshitz Law Firm, P.C.

CXP : 19.00 (-0.16%)
HRC : 150.50 (-0.13%)
KDMN : 8.73 (-1.02%)
JMP : 7.48 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, JMP, KDMN, STMP; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / September 17, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CSOD : 57.15 (-0.12%)
JMP : 7.48 (unch)
KDMN : 8.73 (-1.02%)
STMP : 328.70 (-0.05%)
Lifshitz Law Firm, P.C. Announces Investigation of CXP, HRC, KDMN, and JMP

NEW YORK, NY / ACCESSWIRE / September 15, 2021 / Lifshitz Law Firm, P.C.:

CXP : 19.00 (-0.16%)
HRC : 150.50 (-0.13%)
KDMN : 8.73 (-1.02%)
JMP : 7.48 (unch)
Moore Kuehn Encourages KDMN, NXU, JMP, and HTPA Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown , is investigating potential claims concerning whether the following proposed mergers...

KDMN : 8.73 (-1.02%)
NXU : 9.89 (-0.10%)
JMP : 7.48 (unch)
HTPA : 9.88 (-0.40%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates JMP, KDMN, STMP, GPX; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

JMP : 7.48 (unch)
KDMN : 8.73 (-1.02%)
STMP : 328.70 (-0.05%)
GPX : 20.71 (unch)
Lifshitz Law Firm, P.C. Announces Investigation of CXP, HRC, KDMN, and JMP

NEW YORK, NY / ACCESSWIRE / September 14, 2021 / Columbia Property Trust, Inc. (NYSE:CXP)

CXP : 19.00 (-0.16%)
HRC : 150.50 (-0.13%)
KDMN : 8.73 (-1.02%)
JMP : 7.48 (unch)
Wilson Disease Drugs Market: Trends, Key Players, Overview, Competitive Breakdown and Regional Forecast by 2029

Research Nester has released a report titled "" which delivers detailed overview of the global Wilson disease drugs market in terms of market segmentation by indication, drug type, end-user and by region....

MRK : 71.68 (-0.40%)
BHC : 27.27 (-1.02%)
ALXN : 182.50 (+1.70%)
KDMN : 8.73 (-1.02%)
TEVA : 8.99 (+0.45%)
INVESTIGATION: Halper Sadeh LLP Investigates HRC, JMP, KDMN, BCML, XONE; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

HRC : 150.50 (-0.13%)
JMP : 7.48 (unch)
KDMN : 8.73 (-1.02%)
BCML : 18.30 (-0.44%)
XONE : 23.48 (+0.34%)
KADMON HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kadmon Holdings, Inc. - KDMN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Kadmon Holdings, Inc. (NasdaqGS: KDMN) to Sanofi...

KDMN : 8.73 (-1.02%)
SNY : 48.38 (+0.39%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Kadmon Holdings, Inc.

/PRNewswire/ --  is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Kadmon Holdings, Inc. ("Kadmon Holdings" or the "Company") (NASDAQ: KDMN)...

KDMN : 8.73 (-1.02%)
SNY : 48.38 (+0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Kadmon Holdings Inc. is a biopharmaceutical company. It discovers, develops and delivers transformative therapies for unmet medical needs. The company's product pipeline includes KD025, KD045 and KD033 which are in clinical satge. Kadmon Holdings Inc. is based in New York.

See More

Key Turning Points

3rd Resistance Point 8.95
2nd Resistance Point 8.90
1st Resistance Point 8.82
Last Price 8.73
1st Support Level 8.69
2nd Support Level 8.64
3rd Support Level 8.56

See More

52-Week High 9.20
Last Price 8.73
Fibonacci 61.8% 6.89
Fibonacci 50% 6.17
Fibonacci 38.2% 5.46
52-Week Low 3.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar